hydroxyurea has been researched along with 2,2'-dipyridyl in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barzi, A; Franchetti, P; Nocentini, G | 1 |
| Advani, SH; Basrur, VS; Chitnis, MP; Satyamoorthy, K | 1 |
| Advani, SH; Chitnis, MP; Satyamoorthy, K | 1 |
| Chitnis, MP; Satyamoorthy, K | 1 |
| Chitnis, MP; Pradhan, SG; Satyamoorthy, K | 1 |
| Collins, JJ; Dwyer, DJ; Hayete, B; Kohanski, MA; Lawrence, CA | 1 |
7 other study(ies) available for hydroxyurea and 2,2'-dipyridyl
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.
Topics: 2,2'-Dipyridyl; Animals; Antineoplastic Agents; Chelating Agents; Data Interpretation, Statistical; Drug Screening Assays, Antitumor; Drug Synergism; Hydroxyurea; Leukemia P388; Mice; Ribonucleotide Reductases; Tumor Cells, Cultured | 1990 |
Potentiation of hydroxyurea cytotoxicity in human chronic myeloid leukemia cells by iron-chelating agent.
Topics: 2,2'-Dipyridyl; Antineoplastic Combined Chemotherapy Protocols; Deferoxamine; Drug Synergism; Edetic Acid; Humans; Hydroxybenzoates; Hydroxyurea; In Vitro Techniques; Leukemia, Myeloid; Pyridines | 1986 |
In vitro cytotoxicity of caracemide alone and in combination with hydroxyurea or iron-chelating agents in human chronic myeloid leukemia cells and murine tumors.
Topics: 2,2'-Dipyridyl; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chelating Agents; DNA Replication; DNA, Neoplasm; Drug Synergism; Humans; Hydroxyurea; Leukemia, Myeloid; Mice; Neoplasms, Experimental; Species Specificity; Tumor Cells, Cultured | 1988 |
Hyperthermia blocks reversibility of hydroxyurea and bipyridine induced synergistic inhibition of DNA biosynthesis in P388 murine leukemia cells.
Topics: 2,2'-Dipyridyl; Animals; DNA Replication; Drug Synergism; Hot Temperature; Hydroxyurea; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Pyridines; Thymidine | 1988 |
Potentiation of hydroxyurea cytotoxicity by iron-chelating agent in murine tumor models in vitro.
Topics: 2,2'-Dipyridyl; Animals; Carcinoma, Ehrlich Tumor; Cell Line; DNA, Neoplasm; Drug Synergism; Hydroxyurea; Iron Chelating Agents; Leukemia L1210; Mice; Mice, Inbred DBA; Sarcoma 180 | 1986 |
A common mechanism of cellular death induced by bactericidal antibiotics.
Topics: 2,2'-Dipyridyl; Ampicillin; Anti-Bacterial Agents; Carbon-Sulfur Lyases; Cell Death; Citric Acid Cycle; Colony Count, Microbial; DNA Damage; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Ferrous Compounds; Free Radical Scavengers; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Hydrogen Peroxide; Hydroxyl Radical; Hydroxyurea; Iron Chelating Agents; Kanamycin; Membrane Proteins; Microbial Viability; Mutation; NAD; Norfloxacin; Oxidative Stress; Rec A Recombinases; Staphylococcus aureus; Time Factors | 2007 |